Lidocaine Ointment USP — Class III drug recall D-0785-2021
Terminated recall by Teligent Pharma, Inc., reported 2021-09-08, distributed nationwide. Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through r
| Recall number | D-0785-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teligent Pharma, Inc., Buena, NJ, United States |
| Recall initiated | 2021-07-29 |
| Classified | 2021-08-31 |
| Reported by FDA | 2021-09-08 |
| Terminated | 2024-08-15 |
| Distributed | Nationwide (US) |
| Quantity | 114,456 tubes |
| NDC | 52565-0008-14 |
| Lot numbers | 14418, 15378 |
| Expiration dates | 2021-10, 2023-03 |
Product
Lidocaine Ointment USP, 5% Rx Only, Net Wt 35.44 g(1 1/4 oz)packaged in a laminat tube, Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-008-14.
Reason for recall
Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0785-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.